Trial Profile

A Phase 0, Open-Label, Crossover Microdose Pharmacokinetic Study of PRX-P4-003 In Healthy Volunteers

Status: Completed

Phase of Trial: Phase 0

Latest Information Update: 11 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs PRX-P4-003 (Primary)
Indications Behavioural disorders; Binge-eating disorder
Focus Pharmacokinetics; Proof of concept
Sponsors Praxis Bioresearch

Most Recent Events

09 Nov 2021 According to a Praxis Bioresearch media release, data from this study presented at the 14th Clinical Trials on Alzheimer's Disease (CTAD) meeting.
14 Sep 2021 Planned primary completion date changed from 30 Jun 2021 to 30 Oct 2021.
23 Jun 2021 According to a Praxis Bioresearch media release, data is currently undergoing scientific peer review for publication and/or presentation at the upcoming scientific meetings.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com